Almqvist C, Li Q, Britton W J, Kemp A S, Xuan W, Tovey E R, Marks G B
Woolcock Institute of Medical Research, Camperdown, NSW, Australia; University of Sydney, Sydney, NSW, Australia.
Clin Exp Allergy. 2007 Sep;37(9):1296-302. doi: 10.1111/j.1365-2222.2007.02796.x.
Sensitization and symptoms of allergic disease are strongly correlated, but little is known about the early clinical precursors of the development of allergen sensitization in childhood. The aim of this study was to identify these predictors, and to examine separately the effect of early sensitization on subsequent wheeze, asthma, rhinitis and eczema.
In the Childhood Asthma Prevention Study, children with a family history of asthma were assessed for allergen sensitization, total serum IgE, wheeze, asthma, eczema and rhinitis at ages 18 months and 5 years. To examine predictors, at 18 months, for subsequent sensitization, children who were non-sensitized at 18 months and had data on sensitization at 5 years were investigated, n=375. To examine the predictors, at age 18 months, of subsequent onset of symptoms, children who did not have wheeze, asthma, eczema or rhinitis at 18 months were followed-up at 5 years, n=177.
Among children who were non-sensitized at age 18 months, the presence of eczema [adjusted relative risk (aRR), 1.67, 95% confidence interval (CI) 1.20-2.33], but not wheeze, asthma or rhinitis, was an independent predictor of the onset of sensitization by age 5 years. Among children who were asymptomatic at age 18 months, sensitization to any allergen at 18 months was an independent predictor for the presence of wheeze (aRR 2.41, 95% CI 1.28-4.55), asthma (aRR 4.66, 95% CI 1.88-11.54) and rhinitis (aRR 1.77, 95% CI 1.08-2.90), but not for the development of eczema (aRR 0.78, 95% CI 0.23-2.64) at 5 years.
In non-sensitized children, eczema, but not wheeze, asthma or rhinitis is a predictor for subsequent development of sensitization. This suggests that early childhood eczema, rather than wheeze and rhinitis, may promote subsequent allergen sensitization and raises the possibility that early management of eczema may reduce the prevalence of sensitization in children.
过敏性疾病的致敏作用与症状密切相关,但对于儿童期变应原致敏发展的早期临床先兆知之甚少。本研究的目的是确定这些预测因素,并分别研究早期致敏对随后出现喘息、哮喘、鼻炎和湿疹的影响。
在儿童哮喘预防研究中,对有哮喘家族史的儿童在18个月和5岁时进行变应原致敏、血清总IgE、喘息、哮喘、湿疹和鼻炎评估。为了研究预测因素,在18个月时,对18个月时未致敏且有5岁时致敏数据的儿童进行调查,n = 375。为了研究18个月时症状随后发作的预测因素,对18个月时没有喘息、哮喘、湿疹或鼻炎的儿童在5岁时进行随访,n = 177。
在18个月时未致敏的儿童中,湿疹的存在[校正相对风险(aRR),1.67,95%置信区间(CI)1.20 - 2.33],而非喘息、哮喘或鼻炎,是5岁时致敏发作的独立预测因素。在18个月时无症状的儿童中,18个月时对任何变应原致敏是5岁时出现喘息(aRR 2.41,95% CI 1.28 - 4.55)、哮喘(aRR 4.66,95% CI 1.88 - 11.54)和鼻炎(aRR 1.77,95% CI 1.08 - 2.90)的独立预测因素,但不是湿疹发展的预测因素(aRR = 0.78,95% CI 0.23 - 2.64)。
在未致敏儿童中,湿疹而非喘息、哮喘或鼻炎是随后致敏发展的预测因素。这表明幼儿湿疹而非喘息和鼻炎可能促进随后的变应原致敏,并增加了早期治疗湿疹可能降低儿童致敏患病率的可能性。